Zhou X - Search Results

1

Anti-laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone.

Zhou X, Zhou Y, Qian H, Wu F, Liu H, Li X, Li W. Zhou X, et al. Among authors: zhou y. J Dermatol. 2023 Oct;50(10):e354-e356. doi: 10.1111/1346-8138.16864. Epub 2023 Jun 21. J Dermatol. 2023. PMID: 37341162 No abstract available.

2

Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone.

Zhou XL, Zhan TY, Zhou YH, Shrestha K, Lan TJ, Li W. Zhou XL, et al. Dermatol Ther. 2020 Nov;33(6):e14079. doi: 10.1111/dth.14079. Epub 2020 Sep 4. Dermatol Ther. 2020. PMID: 32713039

3

Identification of novel compound heterozygous ITGB4 mutations in a Chinese woman with junctional epidermolysis bullosa without pylori atresia but profound urinary symptoms: A case report and review of the literature.

Zhou X, Wang M, Wang S, Jiang X, Li W. Zhou X, et al. J Dermatol. 2021 Nov;48(11):1780-1785. doi: 10.1111/1346-8138.16104. Epub 2021 Aug 30. J Dermatol. 2021. PMID: 34462954 Review.

4

Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.

Zhou X, Cheng L, Wang Y, Gou H, Ju K, Lan T, Zhan T, Li G, Gu Y, Sun Y, Xu Y, Sun Y, Zhou Y, Li W. Zhou X, et al. Among authors: zhou y. J Dermatol. 2022 Apr;49(4):402-410. doi: 10.1111/1346-8138.16265. Epub 2021 Dec 5. J Dermatol. 2022. PMID: 34866237 Free PMC article.

5

Secukinumab for PASS syndrome: A new choice for therapeutic challenge?

Li M, Xiang H, Liang Y, Xue L, Zhou X, Yang L, Liu H, Yang M, Tang J, Li W. Li M, et al. Among authors: zhou x. Dermatol Ther. 2022 Jul;35(7):e15507. doi: 10.1111/dth.15507. Epub 2022 Apr 27. Dermatol Ther. 2022. PMID: 35419914

6

Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study.

Li G, Gu Y, Zou Q, Wang Y, Xiao Y, Xia D, Zhan T, Zhou X, Wang Q, Yan W, Li W. Li G, et al. Among authors: zhou x. Dermatol Ther (Heidelb). 2022 Sep;12(9):2105-2115. doi: 10.1007/s13555-022-00787-x. Epub 2022 Aug 11. Dermatol Ther (Heidelb). 2022. PMID: 35953612 Free PMC article.

7

Ixekizumab successfully treated refractory psoriasis concurrent bullous pemphigoid.

Xiao Y, Gu Y, Xia D, Zhou X, Li W. Xiao Y, et al. Among authors: zhou x. J Dermatol. 2023 Feb;50(2):e76-e78. doi: 10.1111/1346-8138.16559. Epub 2022 Aug 26. J Dermatol. 2023. PMID: 36028948 No abstract available.

8

Association of gut microbiome and metabolites with onset and treatment response of patients with pemphigus vulgaris.

Wang Y, Xia X, Zhou X, Zhan T, Dai Q, Zhang Y, Zhang W, Shu Y, Li W, Xu H. Wang Y, et al. Among authors: zhou x. Front Immunol. 2023 Apr 14;14:1114586. doi: 10.3389/fimmu.2023.1114586. eCollection 2023. Front Immunol. 2023. PMID: 37122759 Free PMC article.

9

Effects of ambient temperature on atopic dermatitis and attributable health burden: a 6-year time-series study in Chengdu, China.

Chen Z, Li M, Lan T, Wang Y, Zhou X, Dong W, Cheng G, Li W, Cheng L. Chen Z, et al. Among authors: zhou x. PeerJ. 2023 Apr 24;11:e15209. doi: 10.7717/peerj.15209. eCollection 2023. PeerJ. 2023. PMID: 37123004 Free PMC article.

10

Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review.

Zhou Y, Zhou X, Feng X, Xia D, Qian H, Liu H, Li X, Li W. Zhou Y, et al. Among authors: zhou x. Front Immunol. 2023 May 30;14:1201163. doi: 10.3389/fimmu.2023.1201163. eCollection 2023. Front Immunol. 2023. PMID: 37325615 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,073 results

Search Page

Filters